Shaping the Edible Vaccine Market in 2025: Innovative Oral Cholera Vaccines Drive Advances In The Edible Vaccine Market

How Big Is the Edible Vaccine Market Expected to Be, and What Will Its Growth Rate Be?
In the past few years, the size of the edible vaccine market has experienced robust growth. The market is projected to expand from $8.77 billion in 2024 to $9.6 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.4%. This significant growth in the previous period can be traced back to advancements in genetic engineering, issues with traditional vaccines, progress in biopharming, increased emphasis on worldwide immunization, and escalated funding and government assistance.

Strong expansion is predicted for the size of the edible vaccine market in the upcoming years, anticipated to increase to $13.63 billion by 2029 with a compound annual growth rate (CAGR) of 9.2%. This forecasted growth can be linked to rising pandemic readiness demands, advancement in plant-based biotechnology, heightened public consciousness and approval of genetically altered foods, solutions to cold chain issues, and the alliance with initiatives focusing on food security. The future trends will likely include the broadening into animal health, elevated usage of biopharming, individualized nutrition and immunization, sustainability and eco-friendly vaccines, and the creation of multi-antigen edible vaccines.

What Are the Primary Growth Drivers for the Edible Vaccine Market?
The edible vaccine market's growth is anticipated to be driven by the rising occurrence of infectious diseases. Infectious illnesses are those brought on by dangerous microorganisms like bacteria, viruses, fungi, or parasites, which infiltrate the body and multiply. The escalating rate of such diseases can be attributed to factors like globalization, climate change, urbanization, and antibiotic resistance, all of which aid in the appearance and spread of new pathogens. Genetically modified foods that produce antigens are used in edible vaccines to trigger immune responses, thus providing an economical, needle-free means of vaccination. For example, data from the Centers for Disease Control and Prevention (CDC) in the USA, a public health agency, indicated that tuberculosis cases rose from 8,320 cases in 2022 to 9,615 cases in 2023, an increase of 1,295 cases. The rate per 100,000 individuals also rose, from 2.5 in 2022 to 2.9 in 2023. Consequently, the escalating incidence of infectious diseases is fuelling the growth of the edible vaccine market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp

Who Are the Dominant Companies Influencing Edible Vaccine Market Trends?
Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation

How Is the Edible Vaccine Market Evolving?
Leading corporations in the edible vaccine market are intensively exploring novel solutions such as the Oral Cholera Vaccine (OCV) in an effort to address the worldwide cholera breakout. Oral Cholera Vaccine (OCV) is a unique kind of vaccine taken orally to prevent cholera, a severe intestinal ailment induced by the Vibrio cholerae bacteria. For instance, Bharat Biotech International Limited, a biotechnology firm from India, introduced Hillchol, an Oral Cholera Vaccine (OCV) in August 2024, which has many significant characteristics. This live attenuated vaccine triggers both systemic and mucosal immune reactions, offering protection from cholera. The Hillchol vaccine is distinguished by its easy administration and doesn't demand cold storage, rendering it perfectly suited for use in settings with limited resources. Furthermore, it provides long-term immunity with just a single dosage.

What Are the Different Segmentations in the Edible Vaccine Market?
The edible vaccinemarket covered in this report is segmented -

1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals

Subsegments:
1) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
2) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
3) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Synthetic DNA Vaccines
4) By Live Attenuated Vaccines: Live Attenuated Viral Vaccines, Live Attenuated Bacterial Vaccines
5) By Other Types: Virus-Like Particle (VLP) Vaccines, mRNA Vaccines

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report

Which Region Is at the Forefront of the Edible Vaccine Market?
North America was the largest region in the edible vaccine market in 2024. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Edible Vaccine Global Market Report?

- Market Size Analysis: Analyze the Edible Vaccine Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Edible Vaccine Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Edible Vaccine Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Edible Vaccine Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19040

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.